165 related articles for article (PubMed ID: 16565820)
1. A large preclinical animal model to assess ex vivo skin gene therapy applications.
Pfützner W; Joari MR; Foster RA; Vogel JC
Arch Dermatol Res; 2006 Jun; 298(1):16-22. PubMed ID: 16565820
[TBL] [Abstract][Full Text] [Related]
2. Transplantation of retrovirus-transduced canine keratinocytes expressing the beta-galactosidase gene.
Stockschläder MA; Schuening FG; Graham TC; Storb R
Gene Ther; 1994 Sep; 1(5):317-22. PubMed ID: 7584097
[TBL] [Abstract][Full Text] [Related]
3. The skin as a biofactory for systemic secretion of erythropoietin: potential of genetically modified keratinocytes and fibroblasts.
Scheidemann F; Löser M; Niedermeier A; Kromminga A; Therrien JP; Vogel J; Pfützner W
Exp Dermatol; 2008 Jun; 17(6):481-8. PubMed ID: 18331333
[TBL] [Abstract][Full Text] [Related]
4. Selectable bicistronic vectors in skin gene therapy.
Scheidemann F; Therrien JP; Pfützner W
Arch Dermatol Res; 2008 Sep; 300(8):415-23. PubMed ID: 18663457
[TBL] [Abstract][Full Text] [Related]
5. Topical colchicine selection of keratinocytes transduced with the multidrug resistance gene (MDR1) can sustain and enhance transgene expression in vivo.
Pfützner W; Vogel JC
Cells Tissues Organs; 2004; 177(3):151-9. PubMed ID: 15388989
[TBL] [Abstract][Full Text] [Related]
6. In vivo synthesis and secretion of erythropoietin by genetically modified primary human keratinocytes grafted onto immunocompromised mice.
Scheidemann F; Therrien JP; Vogel J; Pfützner W
Exp Dermatol; 2010 Mar; 19(3):289-97. PubMed ID: 19889025
[TBL] [Abstract][Full Text] [Related]
7. In vivo transduction of mouse epidermis with recombinant retroviral vectors: implications for cutaneous gene therapy.
Ghazizadeh S; Harrington R; Taichman L
Gene Ther; 1999 Jul; 6(7):1267-75. PubMed ID: 10455435
[TBL] [Abstract][Full Text] [Related]
8. Secretion of mouse growth hormone by transduced primary human keratinocytes: prospects for an animal model of cutaneous gene therapy.
Peroni CN; Cecchi CR; Rosauro CW; Nonogaki S; Boccardo E; Bartolini P
J Gene Med; 2008 Jul; 10(7):734-43. PubMed ID: 18389487
[TBL] [Abstract][Full Text] [Related]
9. Onco-retroviral and lentiviral vector-based gene therapy for hemophilia: preclinical studies.
Van Damme A; Chuah MK; Collen D; VandenDriessche T
Semin Thromb Hemost; 2004 Apr; 30(2):185-95. PubMed ID: 15118930
[TBL] [Abstract][Full Text] [Related]
10. Differentiation-specific enhancer activity in transduced keratinocytes: a model for epidermal gene therapy.
Page SM; Brownlee GG
Gene Ther; 1998 Mar; 5(3):394-402. PubMed ID: 9614560
[TBL] [Abstract][Full Text] [Related]
11. Optimised retroviral infection of human epidermal keratinocytes: long-term expression of transduced integrin gene following grafting on to SCID mice.
Levy L; Broad S; Zhu AJ; Carroll JM; Khazaal I; Péault B; Watt FM
Gene Ther; 1998 Jul; 5(7):913-22. PubMed ID: 9813662
[TBL] [Abstract][Full Text] [Related]
12. Cell suspension cultures of allogenic keratinocytes are efficient carriers for ex vivo gene transfer and accelerate the healing of full-thickness skin wounds by overexpression of human epidermal growth factor.
Vranckx JJ; Hoeller D; Velander PE; Theopold CF; Petrie N; Takedo A; Eriksson E; Yao F
Wound Repair Regen; 2007; 15(5):657-64. PubMed ID: 17971011
[TBL] [Abstract][Full Text] [Related]
13. Cutaneous gene transfer and therapy: the present and the future.
Spirito F; Meneguzzi G; Danos O; Mezzina M
J Gene Med; 2001; 3(1):21-31. PubMed ID: 11269332
[TBL] [Abstract][Full Text] [Related]
14. Grafting of large pieces of human reconstructed skin in a porcine model.
Braye FM; Stefani A; Venet E; Pieptu D; Tissot E; Damour O
Br J Plast Surg; 2001 Sep; 54(6):532-8. PubMed ID: 11513518
[TBL] [Abstract][Full Text] [Related]
15. [Expression of vascular cell adhesion molecule 1 in acellular dermal matrix grafting in pigs].
Pan Y; Xu J; Chen S
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2007 Apr; 21(4):382-5. PubMed ID: 17546884
[TBL] [Abstract][Full Text] [Related]
16. Cultured keratinocytes in fibrin with decellularised dermis close porcine full-thickness wounds in a single step.
Bannasch H; Unterberg T; Föhn M; Weyand B; Horch RE; Stark GB
Burns; 2008 Nov; 34(7):1015-21. PubMed ID: 18395990
[TBL] [Abstract][Full Text] [Related]
17. Preclinical study of an ex vivo gene therapy protocol for hepatocarcinoma.
Lortal B; Gross F; Peron JM; Pénary M; Berg D; Hennebelle I; Favre G; Couderc B
Cancer Gene Ther; 2009 Apr; 16(4):329-37. PubMed ID: 18989351
[TBL] [Abstract][Full Text] [Related]
18. Developing a convenient large animal model for gene transfer to salivary glands in vivo.
Li J; Zheng C; Zhang X; Liu X; Zhang C; Goldsmith CM; Baum BJ; Wang S
J Gene Med; 2004 Jan; 6(1):55-63. PubMed ID: 14716677
[TBL] [Abstract][Full Text] [Related]
19. Retroviral-mediated gene therapy for the differentiation of primary cells into a mineralizing osteoblastic phenotype.
Phillips JE; García AJ
Methods Mol Biol; 2008; 433():333-54. PubMed ID: 18679633
[TBL] [Abstract][Full Text] [Related]
20. [Towards gene therapy in familial hypercholesterolemia].
Pagès JC; Andreoletti M; Loux N; Vons C; Mahieu D; Bargy F; Chapman J; Briand P; Franco D; Weber A
C R Seances Soc Biol Fil; 1996; 190(1):53-65. PubMed ID: 8881269
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
